Form 4/A for BGMS Bio Green Med Solution, Inc.
Accepted 2022-06-17 00:00:00 ET · period of report 2022-06-14 · accession 0001104659-22-072381 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2022-06-17 | 2022-06-14 | BGMS | Ferguson Kenneth M. | Dir | A - Grant | $0.00 | +23.7K | 23.7K | New | $0 |
| DA | 2022-06-17 | 2022-06-14 | BGMS | Ferguson Kenneth M. | Dir | A - Grant | $0.00 | +47.5K | 47.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-14 | A | A | 23,733 | $0.00 | 23,733 | D | — | — | (F2) This Form 4 is being amended to correct a typographical error in the number of restricted stock units granted to the Reporting Person on June 14, 2022. 23,733 shares of restricted stock units were granted to the Reporting Person. (F1) The Reporting Person received an award of 23,733 restricted stock units on June 14, 2022, which shall vest in three equal installments on June 14, 2023, June 14, 2024, and June 14, 2025. |
| 2 | Derivative | Stock Option (right to buy) | 2022-06-14 | A | A | 47,467 | $0.00 | 47,467 | D | $1.11 · 2023-06-14 to 2032-06-14 | 47,467 Common Stock | (F3) The option will vest and become exercisable in equal monthly installments for thirty-six months beginning on the date of the grant, which is June 14, 2022, subject to the Reporting Person continuing to provide services to the Issuer through each such vesting date. (F4) These options were granted to Mr. Ferguson for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc. |